newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights

Preliminary Data Demonstrates Normalization of CSF GBA1 Enzyme Activity in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease Patients Company Modifies Protocol for PROPEL...